DOI: 10.1056/NEJMoa2309000

Paper Summary:

Title: A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Author(s): Harrison, Stephen A. (author);Bedossa, Pierre (author);Guy, Cynthia D. (author);Schattenberg, Jörn M. (author);Loomba, Rohit (author);Taub, Rebecca (author);Labriola, Dominic (author);Moussa, Sam E. (author);Neff, Guy W. (author);Rinella, Mary E. (author);Anstee, Quentin M. (author);Abdelmalek, Manal F. (author);Younossi, Zobair (author);Baum, Seth J. (author);Francque, Sven (author);Charlton, Michael R. (author);Newsome, Philip N. (author);Lanthier, Nicolas (author);Schiefke, Ingolf (author);Mangia, Alessandra (author);Pericàs, Juan M. (author);Patil, Rashmee (author);Sanyal, Arun J. (author);Noureddin, Mazen (author);Bansal, Meena B. (author);Alkhouri, Naim (author);Castera, Laurent (author);Rudraraju, Madhavi (author);Ratziu, Vlad (author)

Year: 2024

DOI: 10.1056/NEJMoa2309000

URL: https://doi.org/10.1056/NEJMoa2309000

Download Paper from Sci-Hub:

Generate Citation

✍: FYIcenter.com

2024-08-06, ∼622👍, 0💬